Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Genhong Li"'
Autor:
Genhong Li, Jingwei Yao, Zhen Lu, Lian Yu, Qinwei Chen, Lihong Ding, Zhihong Fang, Yin Li, Bing Xu
Publikováno v:
Drugs in R&D, Vol 23, Iss 4, Pp 439-451 (2023)
Abstract Background The FLT3/ITD mutation exists in many acute myeloid leukemia (AML) patients and is related to the poor prognosis of patients. In this study, we attempted to evaluate the antitumor activity of simvastatin, a member of the statin cla
Externí odkaz:
https://doaj.org/article/d0b6bf8fdaee4b8b94d65283df1be2e0
Autor:
Delin Yuan, Genhong Li, Lian Yu, Yuelong Jiang, Yuanfei Shi, Qiulin Chen, Xiaomei Ma, Lan V. Pham, Ken H. Young, Manman Deng, Zhihong Fang, Bing Xu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
High-grade B-cell lymphoma with concurrent MYC and BCL2 rearrangements (HGBL-DHL) is a rare, aggressive mature B-cell malignancy with a high likelihood of treatment failure following front-line immunochemotherapies. Patients with HGBL-DHL who develop
Externí odkaz:
https://doaj.org/article/6bbd1174d5e54ed6a9c612456baf99c5
Autor:
Chunsheng Zhu, Jianqiu Chen, Yinjian Chen, Ruxin Zhang, Shaoqing Yu, Jiangfeng Tang, Genhong Li
Publikováno v:
Journal of Inflammation, Vol 5, Iss 1, p 23 (2008)
Abstract Background The mechanisms responsible for the development of allergic rhinitis(AR) are not fully understood. The present study was designed to explore the possible roles of carbon monoxide(CO) on the pathogenesis of AR. Methods AR guinea pig
Externí odkaz:
https://doaj.org/article/8209d13000da4026b025b0ed071b0186
Autor:
Xinguo Zhuang, Jingwei Yao, Xun Li, Yuelong Jiang, Mengya Zhong, Jinshui Tan, Hui Zhou, Genhong Li, Jie Zha, Bing Xu
Publikováno v:
International Journal of Medical Sciences; 2024, Vol. 21 Issue 1, p70-79, 10p
Publikováno v:
Environmental Toxicology.
Autor:
Delin, Yuan, Genhong, Li, Lian, Yu, Yuelong, Jiang, Yuanfei, Shi, Qiulin, Chen, Xiaomei, Ma, Lan V, Pham, Ken H, Young, Manman, Deng, Zhihong, Fang, Bing, Xu
Publikováno v:
Frontiers in Oncology
High-grade B-cell lymphoma with concurrent MYC and BCL2 rearrangements (HGBL-DHL) is a rare, aggressive mature B-cell malignancy with a high likelihood of treatment failure following front-line immunochemotherapies. Patients with HGBL-DHL who develop
Publikováno v:
Applied Nanoscience. 13:3141-3141
Autor:
Yuelong Jiang, Lihong Ding, Manman Deng, Qiuling Chen, Dongyu Bai, Qinwei Chen, Kai Chen, Hai-ping Zhang, Bing Xu, Dehong Gao, Genhong Li
Publikováno v:
European Journal of Pharmacology. 913:174633
Constitutively activated BCR-ABL kinase is considered the driver event responsible in the initiation and development of chronic myeloid leukemia (CML). The advent of the first BCR-ABL inhibitor imatinib has significantly improved the clinical outcome
Publikováno v:
Blood. 136:41-41
High-grade B-cell lymphoma with concurrentMYCandBCL2rearrangements (HGBCL-DHL) is a rare and aggressive B-cell disorder with a high likelihood of nonresponsiveness to the front-line immunochemotherapy. Patients with HGBCL-DHL who develop a recurrent
Publikováno v:
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery. 28(17)
To investigate the clinical relationship between allergic rhinitis and allergic factors with chronic rhinosinusitis with or without nasal polyps.Two hundred patients were divided into A and B two groups. Group A of 110 patients was diagnosed allergic